Targeting autophagy to overcome drug resistance: further developments
Related Experiment Video
Updated: Nov 28, 2025

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Haocai Chang1,2, Zhengzhi Zou3,4
1MOE Key Laboratory of Laser Life Science and Institute of Laser Life Science, College of Biophotonics, South China Normal University, Guangzhou, 510631, China.
Abstract:
Inhibiting cell survival and inducing cell death are the main approaches of tumor therapy. Autophagy plays an important role on intracellular metabolic homeostasis by eliminating dysfunctional or unnecessary proteins and damaged or aged cellular organelles to recycle their constituent metabolites that enable the maintenance of cell survival and genetic stability and even promotes the drug resistance, which severely limits the efficacy of chemotherapeutic drugs. Currently, targeting autophagy has a seemingly contradictory effect to suppress and promote tumor survival, which makes the effect of targeting autophagy on drug resistance more confusing and fuzzier. In the review, we summarize the regulation of autophagy by emerging ways, the action of targeting autophagy on drug resistance and some of the new therapeutic approaches to treat tumor drug resistance by interfering with autophagy-related pathways. The full-scale understanding of the tumor-associated signaling pathways and physiological functions of autophagy will hopefully open new possibilities for the treatment of tumor drug resistance and the improvement in clinical outcomes.
Insights
Targeting autophagy, a cellular recycling process, presents a complex challenge in cancer therapy. Understanding its dual role in promoting and suppressing tumor survival is key to overcoming drug resistance.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Tumor therapy primarily focuses on inhibiting cancer cell survival and inducing cell death.
- Autophagy is crucial for cellular homeostasis, recycling cellular components, and maintaining cell survival and genetic stability.
- Autophagy can promote drug resistance, limiting the effectiveness of chemotherapy.
Purpose of the Study:
- To review the regulation of autophagy by emerging methods.
- To analyze the impact of targeting autophagy on drug resistance in tumors.
- To discuss novel therapeutic strategies for overcoming tumor drug resistance by modulating autophagy.
Main Methods:
- Literature review of autophagy regulation.
- Analysis of studies on autophagy targeting and drug resistance.
- Exploration of emerging therapeutic approaches interfering with autophagy pathways.
Main Results:
- Autophagy's role in tumor survival and drug resistance is complex and often contradictory.
- Targeting autophagy can have dual effects, potentially suppressing or promoting tumor survival.
- Interfering with autophagy-related pathways offers potential for novel cancer therapies.
Conclusions:
- A comprehensive understanding of autophagy's role in cancer signaling is essential.
- Modulating autophagy pathways holds promise for overcoming tumor drug resistance.
- Further research may lead to improved clinical outcomes in cancer treatment.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

